Showing results (571-580 of 657) with videos related to
Sort By:
Pageof 66
Infectious Diseases and Therapy|November 7, 2025
Clinical Impact of Implementing a Specific Clinical Pathway for the Management of Clostridioides difficile InfectionMiguel Rodríguez-Fernández, Rocio Herrero, Pilar González-De-La-Aleja, et al.Clinical and Experimental Rheumatology|December 21, 2022
Characterisation of the coexistence between sarcoidosis and Sjögren's syndrome. Analysis of 43 patientsAlejandra Flores-Chavez, Wan-Fai Ng, Alessia Alunno, et al.Frontiers in Medicine|July 25, 2022
Pathological Findings Associated With SARS-CoV-2 on Postmortem Core Biopsies: Correlation With Clinical Presentation and Disease CourseJose-Manuel Ramos-Rincon, Cristian Herrera-García, Sandra Silva-Ortega, et al.Journal of Pediatric Gastroenterology and Nutrition|June 3, 2014
Spanish national registry of celiac disease: incidence and clinical presentationM Luz Cilleruelo, Enriqueta Roman-Riechmann, Felix Sanchez-Valverde, et al.European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL studyZsuzsanna Kahan, Miguel Gil-Gil, Manuel Ruiz-Borrego, et al.Annals of the Rheumatic Diseases|February 3, 2022
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndromeGeorge C Drosos, Daisy Vedder, Eline Houben, et al.Clinical and Experimental Rheumatology|June 29, 2026
Predictors of mortality in sarcoidosis: a nationwide cohort study from the SARCOGEAS registryCarlos Feijoo-Massó, Alex Mayer-Fuentes, Alejandra Flores-Chávez, et al.Internal and Emergency Medicine|November 29, 2021
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 RegistryFrancesc Formiga, Manuel Rubio-Rivas, José María Mora-Luján, et al.The New England Journal of Medicine|December 3, 2010
Adjuvant docetaxel for high-risk, node-negative breast cancerMiguel Martín, Miguel A Seguí, Antonio Antón, et al.Cancers|October 14, 2022
Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM StudyVirginia Lope, Angel Guerrero-Zotano, Emma Ruiz-Moreno, et al.Pageof 66